{"extraction_ratio": 0.99, "to_compare": [{"generated": [], "gold": []}, {"generated": ["rhabdomyolysis", "heavy toxicity", "retroperitoneal liposarcoma"], "gold": ["rhabdomyolysis", "retroperitoneal liposarcoma", "adverse event"]}, {"generated": ["abdominal mass"], "gold": []}, {"generated": ["lesion progressed rapidly", "16 \u00d7 10 cm", "retro-peritoneum space"], "gold": []}, {"generated": ["absence of co-morbidity"], "gold": []}, {"generated": ["treatment-induced toxicity", "cancer-related syndromes"], "gold": ["cancer", "cancer-related syndromes", "treatment-induced toxicity"]}, {"generated": ["activation of the death receptor", "inhibition of transport mechanisms"], "gold": []}, {"generated": ["health risks", "medicinal cannabis"], "gold": []}, {"generated": [], "gold": ["chronic back pain"]}, {"generated": ["Parkinson's disease (PD)"], "gold": ["PD"]}, {"generated": [], "gold": ["adverse drug events"]}, {"generated": ["chronic neck, back, and shoulder pain", "spinal stenosis", "vitamin D deficiency"], "gold": ["PD", "spinal stenosis", "vitamin D deficiency", "frequent falls", "mild kidney disease", "chronic neck, back, and shoulder pain"]}, {"generated": ["tremors"], "gold": ["tremors"]}, {"generated": [], "gold": []}, {"generated": [], "gold": ["pain", "healthy"]}, {"generated": [], "gold": []}, {"generated": ["COMT Met/Met", "higher levels of dopamine", "genotype", "PGx results"], "gold": []}, {"generated": ["hallucinations"], "gold": ["PD", "hallucinations"]}, {"generated": [], "gold": ["pain"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cancer"], "gold": ["cancer"]}, {"generated": ["29% to 83%", "range"], "gold": []}, {"generated": ["very narrow therapeutic indices"], "gold": []}, {"generated": ["increasing number of studies"], "gold": []}, {"generated": ["HDIs", "herb products"], "gold": []}, {"generated": ["hypoglycemic effect"], "gold": ["hypoglycemic"]}, {"generated": ["traditional hypoglycemic herbs"], "gold": ["hypoglycemic"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["deleterious", "chronic use"], "gold": []}, {"generated": ["indigenous mode of extraction"], "gold": []}, {"generated": ["pharmacotherapy", "drug-nutrient interactions", "adverse drug reactions", "pharmacology", "pharmacodynamics", "pathology", "drug-induced diseases", "drug-drug interactions", "drug-food interactions", "drug-related toxicities", "drug-genetic interactions", "pharmacokinetics", "drug-disease interactions"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["in vitro-in vivo-extrapolation (IVIVE)", "Drug-Drug Interaction (DDI)"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["type 2 diabetes"], "gold": ["type 2 diabetes"]}, {"generated": ["diabetic patients"], "gold": ["diabetic"]}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["gliclazide", "caffeine-containing beverages", "grapefruit"], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": ["CL/Fs of tolbutamide", "CL/Fs of glipizide"], "gold": []}, {"generated": ["No specific pathologies or side effects mentioned in the provided text"], "gold": []}, {"generated": ["Epstein Barr virus (EBV)", "acute cytomegalovirus (CMV)"], "gold": ["acute cytomegalovirus (CMV", "Epstein Barr virus (EBV"]}, {"generated": ["Antinuclear antibody (ANA)", "smooth muscle antibody"], "gold": []}, {"generated": ["periportal hepatocyte apoptosis", "fibroinflammatory expansion of portal tracts", "cholangiolar proliferation", "chronic hepatitis", "plasma cell rich interface hepatitis"], "gold": ["chronic hepatitis", "interface hepatitis"]}, {"generated": ["clinicopathological features"], "gold": []}, {"generated": ["lower extremity edema", "right upper quadrant abdominal pain", "fatigue"], "gold": ["right upper quadrant abdominal pain", "fatigue", "lower extremity edema"]}, {"generated": [], "gold": ["menopause"]}, {"generated": ["liver failure"], "gold": ["liver failure"]}, {"generated": ["autoimmune response"], "gold": []}, {"generated": ["Adverse Drug Reactions"], "gold": ["Adverse Drug Reactions"]}, {"generated": ["black cohosh hepatotoxicity"], "gold": ["hepatotoxicity"]}, {"generated": ["bacterial infections"], "gold": []}, {"generated": ["urinary system infection"], "gold": ["urinary system infection"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Group one"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["current studies at the pharmacokinetic level"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["swollen lymph nodes", "Kyasanur Forest disease", "rash", "fever", "headache", "body aches", "pustules", "monkeypox", "fatigue"], "gold": []}, {"generated": ["diabetes"], "gold": ["diabetes"]}, {"generated": [], "gold": ["anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties"]}, {"generated": [], "gold": []}, {"generated": ["digoxin"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["calcein-AM", "digoxin", "P-gp inhibition"], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["diabetes", "obesity"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["inhibitory effects on the respective enzymes"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C8 inhibitor", "CYP3A4 inhibitor", "CYP2C9 inhibitor"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["statistically not significant"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["grade 3 and 4 toxicities"], "gold": ["toxicities", "Cancer", "Adverse Events"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["docetaxel"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["midazolam studies", "alkylamides", "contents of DTAI"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacokinetics of docetaxel"], "gold": []}, {"generated": ["cancer"], "gold": ["cancer"]}, {"generated": ["advanced cancer"], "gold": ["tumour", "advanced cancer"]}, {"generated": ["CYP3A4-mediated interactions"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["adverse events"], "gold": ["adverse events"]}, {"generated": ["adverse events"], "gold": ["adverse events"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Rat"], "gold": []}, {"generated": ["Rat"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["rheumatoid arthritis"], "gold": ["rheumatoid arthritis"]}, {"generated": ["rheumatoid arthritis"], "gold": ["rheumatoid arthritis"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["red ginseng extract"], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": ["Renal Glomerular Epithelial Dysfunction", "Tubular Epithelial Damage", "Glomerular Basement Membrane Alterations", "Renal Tubular Epithelial Damage", "Renal Tubular Dysfunction"], "gold": []}, {"generated": ["2016; Bautista et al."], "gold": []}, {"generated": ["2014; Dybro et al."], "gold": []}, {"generated": ["interaction between AC and DST"], "gold": []}, {"generated": ["3.5 \u03bcm"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["large individual differences in the effects of the drug"], "gold": []}, {"generated": ["side effects", "further in-depth studies", "controversial"], "gold": []}, {"generated": ["combinations with Western drugs"], "gold": []}, {"generated": ["elevated or false-positive digoxin plasma concentration monitoring results"], "gold": ["patients", "renal dysfunction"]}, {"generated": ["digoxin"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": ["ventricular tachycardia", "ventricular precontraction", "arrhythmia", "ventricular fibrillation"], "gold": ["ventricular precontraction, ventricular tachycardia,", "ventricular fibrillation", "arrhythmia", "arrhythmias", "ventricular arrhythmias", "arrhythmias"]}, {"generated": ["imbalance of qi, blood, yin and yang"], "gold": []}, {"generated": ["digoxin"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["digoxin"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cognitive decline"], "gold": ["cognitive decline"]}, {"generated": [], "gold": []}, {"generated": ["C. asiatica"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": ["percentage control value"], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": ["Prism 8.0.2", "curve fitting"], "gold": []}, {"generated": ["Not specified in the provided text"], "gold": []}, {"generated": ["side effects", "pathology", "drug-induced conditions", "toxic effects", "adverse effects"], "gold": []}, {"generated": ["side effects", "pathology", "drug-induced conditions", "toxic effects", "adverse effects"], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Not specified in the provided text"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["triplicate determinations"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CA derivatives"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["hypertension", "chronic kidney disease"], "gold": ["hypertension", "chronic kidney disease"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["hypertension"]}, {"generated": ["previous reports", "mass fragmentation patterns", "product ion mass spectra"], "gold": []}, {"generated": ["M.P."], "gold": []}, {"generated": [], "gold": []}, {"generated": ["chronic nature of HAART administration"], "gold": []}, {"generated": ["improvement of the quality of life for people taking ART"], "gold": []}, {"generated": ["nausea", "fever", "headache", "diarrhoea", "vomiting", "dyslipidemia", "liver damage"], "gold": ["side effects", "liver damage", "nausea", "vomiting", "fever", "diarrhoea", "dyslipidemia", "headache"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned in the text provided"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["GGT"], "gold": []}, {"generated": ["common cold"], "gold": ["common cold"]}, {"generated": [], "gold": []}, {"generated": ["GGT (7680 mg)", "AAP at 1000 once a day", "1000 mg"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Q.T.T.", "modeling", "H.-y.Y.", "L.T.N.", "J.-w.C.", "H.-m.B."], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["patients taking prescription medications"], "gold": []}, {"generated": ["age-related changes"], "gold": []}, {"generated": ["adherence", "probe drug administration"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no serious adverse events"], "gold": []}, {"generated": ["95% confidence intervals", "phenotypic ratios"], "gold": []}, {"generated": ["St. John\u2019s wort"], "gold": []}, {"generated": ["young individuals", "earlier study"], "gold": []}, {"generated": ["St. John\u2019s wort"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["elderly patients", "anticoagulant therapy"], "gold": []}, {"generated": ["platelet activating factor"], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["specific CYP isoforms"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["plasma quinine", "3-hydroxyquinine"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["adverse side effects from taking G. kola seeds"], "gold": ["Pregnancy", "breastfeeding", "hypersensitivity", "adverse side effects"]}, {"generated": [], "gold": ["healthy"]}, {"generated": ["quinine sulphate tablets", "overnight fast"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["3-hydroxyquinine"], "gold": []}, {"generated": ["reduced AUC0\u2013\u221e of quinine"], "gold": []}, {"generated": ["dizziness"], "gold": ["light dizziness"]}, {"generated": [], "gold": []}, {"generated": ["CL/F", "T1/2", "quinine"], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["HIV positive"]}, {"generated": ["MOS-HIV"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["high density lipoprotein", "low density lipoprotein"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["pathologies or side effects found in the text"], "gold": []}, {"generated": ["side effects", "occurrence", "prevalence"], "gold": []}, {"generated": ["Chronic kidney disease (CKD)"], "gold": ["Chronic kidney disease (CKD)"]}, {"generated": ["interactions with other drugs"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["congenital kidney disease", "polycystic kidney disease", "acute kidney injury", "drug-induced renal failure"], "gold": ["congenital kidney disease", "polycystic kidney disease", "drug-induced renal failure", "acute kidney injury"]}, {"generated": [], "gold": []}, {"generated": ["prevalent among middle-aged (50\u201364) patients"], "gold": []}, {"generated": ["respiratory problems", "common cold"], "gold": []}, {"generated": ["27"], "gold": []}, {"generated": ["neurological deficiencies", "Karnofsky performance status scale"], "gold": ["neurological deficiencies"]}, {"generated": ["positron emission tomography positive residual tumor"], "gold": ["tumor"]}, {"generated": ["interactions with herbal formulas"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["clotting time"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["S-warfarin"], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned"], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["atrial fibrillation"], "gold": ["atrial fibrillation"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["adverse interactions", "anticancer drugs"], "gold": ["cancer patients"]}, {"generated": [], "gold": []}, {"generated": ["elderly"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["potential bias in the presentation of results and conclusions", "completeness and validity of data", "clinical relevance of the results"], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": ["drug-induced liver injury", "liver toxicity", "hepatotoxicity"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Not specified in the provided text"], "gold": []}, {"generated": ["drugs", "pharmacodynamic interaction"], "gold": []}, {"generated": ["delirium", "opioids"], "gold": ["delirium"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacodynamic interactions"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned in the provided text"], "gold": []}, {"generated": ["CYP3A induction", "CYP3A inhibition"], "gold": []}, {"generated": ["antidepressant"], "gold": []}, {"generated": ["left ventricular ejection fraction (LVEF)", "radiological abnormalities"], "gold": ["the radiological abnormalities"]}, {"generated": ["drug-induced cardiopulmonary toxicity"], "gold": ["drug-induced cardiopulmonary toxicity"]}, {"generated": ["DIP"], "gold": ["DIP", "DIP"]}, {"generated": ["cardiopulmonary toxicity"], "gold": ["cardiopulmonary toxicity"]}, {"generated": ["doen\u00e7as autoimunes"], "gold": []}, {"generated": ["manifesta\u00e7\u00e3o cl\u00ednica", "acumula\u00e7\u00e3o t\u00f3xica"], "gold": []}, {"generated": ["par\u00e2metros renais", "prote\u00ednas do complemento", "par\u00e2metros hep\u00e1ticos", "sedimento urin\u00e1rio"], "gold": []}, {"generated": ["major side effects"], "gold": []}, {"generated": ["previamente h\u00edgida"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["menopausal symptoms"]}, {"generated": [], "gold": ["menopausal", "surgery", "hysterectomy", "endometrial hyperplasia", "endometrial, breast, or sex hormone\u2013related cancers", "uncontrolled hypertension", "uncontrolled diabetes mellitus", "diabetes", "uncontrolled thyroid", "severe migraines", "thromboembolism", "cerebrovascular disease", "cardiovascular disease", "uterine bleeding", "menopause", "drug or alcohol abuse", "hypersensitivity"]}, {"generated": ["adverse reactions", "degree and result of the adverse reaction"], "gold": ["adverse reactions", "adverse reaction", "adverse reactions"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["headache", "hot flash", "pruritus"], "gold": ["pruritus", "hot flash", "headache"]}, {"generated": ["severe adverse reactions"], "gold": ["adverse reactions"]}, {"generated": ["large-scale menopausal subjects"], "gold": ["menopausal"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["competitive inhibition"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["13-fold variability", "serotonin glucuronidation", "120-fold variability"], "gold": []}, {"generated": ["metabolism of drugs", "clofibric acid", "valproic acid"], "gold": []}, {"generated": ["previous study"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["chronic liver disease"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["potential for interactions with other drugs"], "gold": []}, {"generated": ["deviation of \u00b11 day"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["PCOS"], "gold": ["Oxidative stress", "PCOS"]}, {"generated": ["PCOS (Polycystic Ovary Syndrome)"], "gold": ["side effects", "PCOS"]}, {"generated": ["decreases blood glucose", "decreases insulin"], "gold": []}, {"generated": [], "gold": ["OS"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["described pathologies or side effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no significant difference in the FBS level", "HOMA-IR level", "insulin level"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["hypoglycemic"], "gold": []}, {"generated": ["glucose levels", "hypolipidemic effects", "reduction of insulin tolerance"], "gold": []}, {"generated": ["study"], "gold": []}, {"generated": [], "gold": ["PCOS"]}, {"generated": ["Polycystic ovary syndrome (PCOS)"], "gold": ["Polycystic ovary syndrome (PCOS)"]}, {"generated": [], "gold": []}, {"generated": ["HIV strains"], "gold": ["HIV", "AIDS"]}, {"generated": ["V05895B"], "gold": []}, {"generated": ["physical examination", "HIV-1 RNA load", "clinical interview", "CD4+ T-cell count"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CD4+ T-cell count"], "gold": []}, {"generated": ["HIV-1 RNA load"], "gold": ["patient", "adverse events"]}, {"generated": ["Darunavir"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no evident safety issue of concern"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": ["disorders"]}, {"generated": [], "gold": []}, {"generated": ["DOR", "OME", "DEX", "5-OH-OME"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["CYPs"], "gold": []}, {"generated": ["CYP2C9", "CYP1A2"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["two reviewers", "standard eligibility inclusion criteria"], "gold": []}, {"generated": ["bioanalytical data", "side effects", "herbal preparations", "pathological conditions"], "gold": []}, {"generated": ["attrition", "withdrawal"], "gold": []}, {"generated": ["high risk of bias", "unclear risk of bias"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["herbal medicines", "PD interactions"], "gold": []}, {"generated": ["herb-warfarin interaction"], "gold": []}, {"generated": ["misleading conclusions", "case reports"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["hepatic damage"], "gold": []}, {"generated": ["no pathologies or side effects mentioned"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["activated partial thromboplastin time (aPTT)", "prothrombin time (PT)", "international normalized ratio (INR)"], "gold": []}, {"generated": ["disseminated intravascular coagulation (DIC)", "pathologic inhibitors of coagulation", "vitamin K malabsorption", "coagulopathy of unknown origin"], "gold": ["coagulopathy", "disseminated intravascular coagulation (DIC)", "vitamin K malabsorption", "pathologic inhibitors of coagulation"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["adverse events"]}, {"generated": [], "gold": []}, {"generated": ["ADME processes", "herb\u2013drug interactions"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["curcumin"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["hurdles", "comprehensive systematic review", "CBZ"], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned directly in the text provided"], "gold": []}, {"generated": ["2012"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["epilepsy"], "gold": ["epilepsy"]}, {"generated": ["antiepileptic therapy"], "gold": ["Patients"]}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": ["other English databases (AMED, CINAHL Plus, Cochrane Database of Systematic Reviews, CENTRAL, SciFinder Scholar)", "Chinese databases", "conventional databases (EMBASE, MEDLINE)"], "gold": []}, {"generated": ["cycloserine (CBZ)"], "gold": []}, {"generated": ["side effects", "caution"], "gold": []}, {"generated": ["nausea", "bipolar disorder", "skin rash", "major depression", "blurred vision", "dizziness"], "gold": ["dizziness", "blurred vision", "skin rash", "nausea", "major depression", "bipolar disorder"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["variables", "side effects", "significant relationship"], "gold": []}, {"generated": ["summary characteristics of interviewed patients"], "gold": []}, {"generated": ["type-2 diabetes"], "gold": ["type-2 diabetes"]}, {"generated": ["hypoglycaemic agents"], "gold": []}, {"generated": ["diabetes"], "gold": ["diabetes"]}, {"generated": [], "gold": ["diabetes"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["hepatocellular carcinoma"], "gold": ["carcinoma"]}, {"generated": [], "gold": []}, {"generated": ["22 compounds identified or tentatively identified"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["liver drug enzymes"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["PON"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["control group", "side effects", "significant differences"], "gold": []}, {"generated": ["pharmacological safety", "herbal medicines"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["L-MDR1 cells", "human P-glycoprotein (P-gp)"], "gold": []}, {"generated": ["CYP3A4", "CYP2C19"], "gold": []}, {"generated": ["aryl hydrocarbon receptor (AhR)"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["BCRP"], "gold": []}, {"generated": ["cyclosporine A", "positive controls rifampicin"], "gold": []}, {"generated": ["induction assay"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects", "evaluated"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["P388/dx cells", "MDCKII-BCRP cells", "AZ-AhR cells", "HEK-OATP1B1 cells", "P388", "HEK-OATP1B3 cells"], "gold": ["Cancer"]}, {"generated": ["p < 0.01", "p < 0.05"], "gold": []}, {"generated": ["reporter gene assays"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["medications", "side effects"], "gold": []}, {"generated": ["CYP2B6 genotyping"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "processed", "analytical data"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no pathologies or side effects mentioned"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["various malignancies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["BCPR/ABCG2 protein"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["radical alteration"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["2 hours after APG 40 mg/kg administration", "7th day"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "APG\u2013DAS interaction", "in vivo studies"], "gold": []}, {"generated": ["pathologies or side effects found in the text"], "gold": []}, {"generated": ["K.M.A.", "supervision"], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "drug-related diseases", "pharmacology", "drug-resistant conditions", "drug-induced conditions", "drug-sensitive conditions", "adverse effects", "toxicities", "drug reactions", "pathologies"], "gold": []}, {"generated": ["Hepatic", "intestinal"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["herb-mediated changes in CYP activity"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Resting lactate level"], "gold": []}, {"generated": ["high lactate production", "reduced oxidative metabolism"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pregnane\u2010X\u2010receptor (PXR) activation"], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": ["depression"], "gold": ["depression"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cancer therapies"], "gold": ["cancer"]}, {"generated": ["clinical outcomes", "beneficial interactions", "harmful interactions", "mechanistic explanations"], "gold": ["cancer"]}, {"generated": [], "gold": []}, {"generated": ["literature selection", "process of database searching"], "gold": []}, {"generated": ["WBC (CD3+, CD4+ T cells, NK cells)", "T cell apoptosis", "caspase 3 activity", "intestinal damage caused by 5-FU", "platelets"], "gold": ["intestinal damage", "metastasis"]}, {"generated": ["metastasis", "tumor recurrence"], "gold": ["tumor", "metastasis"]}, {"generated": ["tumor cell angiogenesis", "reactive oxygen species production"], "gold": []}, {"generated": ["tumor metabolism", "gut dysbiosis"], "gold": ["gut dysbiosis"]}, {"generated": ["lipid peroxide levels", "suppressor T cells", "tumor-infiltrating lymphocytes", "superoxide dismutase (SOD)", "cytotoxicity", "anticancer drugs"], "gold": ["cancer"]}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["T cell balance", "T helper cell balance", "T cell apoptosis", "immune responses"], "gold": []}, {"generated": ["adverse effects of chemotherapeutic drugs"], "gold": ["adverse effects"]}, {"generated": ["pathologies or side effects found in the text"], "gold": []}, {"generated": ["drug interactions", "adverse drug reactions", "pharmacology", "drug tolerance", "pharmacodynamics", "drug-related side effects", "drug resistance", "drug hypersensitivity", "drug-drug interactions", "drug-induced organ toxicity", "drug-induced organ failure", "drug-induced organ damage", "drug-induced organ dysfunction", "pharmacokinetics", "therapeutic drug monitoring", "medication-induced conditions"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["breast cancer"], "gold": ["breast cancer", "side effects", "cancer"]}, {"generated": ["breast tumors", "estrogen receptor (ER) positive"], "gold": ["breast tumors", "ER-positive breast cancer"]}, {"generated": ["other types of cancer", "breast cancer"], "gold": ["breast cancer", "cancer"]}, {"generated": ["total mistletoe lectin concentration"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["proliferation"], "gold": []}, {"generated": ["patients"], "gold": []}, {"generated": ["breast cancer"], "gold": ["breast cancer"]}, {"generated": ["genetic polymorphisms", "inter-individual variability"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["daily for two weeks at morning"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["captopril analysis", "within-run precision", "within-run accuracy"], "gold": []}, {"generated": ["selectivity testing"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["reaction"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["2016; Eng et al."], "gold": []}, {"generated": ["drug-induced liver injury", "hepatotoxicity"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacology", "translational science"], "gold": []}, {"generated": ["drug-induced liver injury", "liver toxicity", "liver dysfunction", "liver enzyme elevation", "liver damage", "hepatotoxicity"], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": ["T.O. syndrome", "H.O. syndrome", "R.T. syndrome", "E.H. syndrome", "Y.O. syndrome", "K.S. syndrome", "S.M. syndrome"], "gold": []}, {"generated": ["R.T.", "K.S.", "H.W.", "J.K.", "Y.O.", "M.F.", "S.M."], "gold": []}, {"generated": ["diabetes mellitus"], "gold": ["diabetes mellitus"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["diabetic"]}, {"generated": [], "gold": []}, {"generated": ["seven days"], "gold": []}, {"generated": ["filtered", "previous filtrate"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathology", "drug-induced diseases", "adverse effects", "toxicities"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["diabetes", "oxidative stress", "inflammatory response", "liver damage"], "gold": ["diabetes", "liver damage", "oxidative stress", "aberrant inflammatory response"]}, {"generated": ["mean \u00b1 standard error of measurement (SEM)"], "gold": []}, {"generated": ["significantly different from diabetic control group", "significantly different from normal group"], "gold": ["diabetic"]}, {"generated": ["elevated levels of BUN"], "gold": []}, {"generated": ["drug-induced liver injury", "hepatotoxicity"], "gold": []}, {"generated": ["significantly different from diabetic control group", "significantly different from normal group"], "gold": ["diabetic"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["model group", "M-AOE group"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["indomethacin-induced gastric injury"], "gold": ["gastric injury"]}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["anticoagulant therapy"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["warfarin"], "gold": []}, {"generated": ["atrial fibrillation"], "gold": ["bleeding", "atrial fibrillation"]}, {"generated": ["prosthetic heart valves", "warfarin"], "gold": ["prosthetic heart"]}, {"generated": ["no specific pathologies or side effects mentioned"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["reduces blood pressure"], "gold": []}, {"generated": [], "gold": ["antihypertensive, antioxidant, and hypocholesterolemic"]}, {"generated": [], "gold": ["antioxidant activity"]}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["triglycerides", "total cholesterol", "cholesterol", "HDL-C", "LDL-C"], "gold": []}, {"generated": ["significant increase in total cholesterol"], "gold": ["hypertensive"]}, {"generated": [], "gold": []}, {"generated": [], "gold": ["hypotensive activity,", "vasodilation"]}, {"generated": ["hepatotoxic"], "gold": ["hepatotoxic"]}, {"generated": ["diuretic effects", "electrolyte levels"], "gold": ["diuretic effects"]}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["noncompetitive", "competitive", "mixed-inhibition"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["mechanism\u2010based inhibition"], "gold": []}, {"generated": ["chronic exposure"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cancer cell lines"], "gold": ["anti\u2010cancer activity"]}, {"generated": ["haemorrhage"], "gold": ["haemorrhage"]}, {"generated": ["Danshen", "warfarin", "Gegen"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned directly in the text provided"], "gold": []}, {"generated": ["inhibiting platelet aggregation", "improving microcirculation", "inhibiting the activity of VKOR", "anticoagulant effect", "inducing TM"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Gegen"], "gold": []}, {"generated": ["interact with warfarin", "interactions between Gegen and warfarin", "case reports"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["warfarin dose"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["warfarin hydroxylation"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["liver cytochrome P450"], "gold": []}, {"generated": [], "gold": ["early stage breast cancer"]}, {"generated": ["publication by (Beer et al.)"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["adjuvant chemotherapy"], "gold": []}, {"generated": ["competing interests"], "gold": []}, {"generated": ["diabetes", "malaria fever", "hyperlipidemia", "hypertension"], "gold": ["diabetes", "hypertension", "hyperlipidemia", "malaria fever"]}, {"generated": ["cancer", "diabetes", "hypertension", "antimicrobials", "asthma", "malaria", "peptic ulcer"], "gold": ["hypertension", "diabetes", "asthma", "peptic ulcer", "cancer"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["no specific pathologies or side effects mentioned in the provided text"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["menopause symptoms"]}, {"generated": ["cognitive declines", "sexual dysfunction", "sleep disturbances", "night sweats", "weight gain", "hot flashes", "mood disorders", "problematic symptoms"], "gold": ["menopause", "hot flashes", "night sweats", "sleep disturbances", "sexual dysfunction", "mood disorders", "weight gain", "cognitive declines"]}, {"generated": ["no specific pathologies or side effects mentioned in the provided text"], "gold": []}, {"generated": ["side effects", "half-maximal inhibitory concentration (IC50)", "approval No.", "ethics committees"], "gold": []}, {"generated": ["neurologic disease/disorder", "dermatologic disease", "endocrine disease", "hepatic disease", "pulmonary disease", "gastrointestinal disease", "hematologic disease", "renal disease", "cardiovascular disease", "immunologic disease"], "gold": ["cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, or neurologic disease/disorder"]}, {"generated": ["breastfeeding", "pregnancy", "planning to conceive"], "gold": []}, {"generated": ["MenoAct851 formulation"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": ["significant", "differences", "P < 0.05"], "gold": []}, {"generated": ["simvastatin"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["bleeding", "severe fatigue"], "gold": ["Fatigue", "Bleeding", "severe fatigue", "bleeding", "ischemic heart disease", "hypertension", "diabetes"]}, {"generated": ["drug interactions"], "gold": ["illnesses"]}, {"generated": ["medication interactions", "possible interactions", "interactions between medication and lifestyle", "lifestyle interactions"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C9*3", "CYP2C9*1", "CYP2C9*2"], "gold": []}, {"generated": ["adverse events", "herbal medicines", "warfarin"], "gold": ["adverse events"]}, {"generated": ["Arachidonic acid", "Collagen", "ADP"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["No specific pathologies or side effects mentioned in the provided text snippet"], "gold": []}, {"generated": ["previous studies", "discrepancy"], "gold": []}, {"generated": [], "gold": ["cancer"]}, {"generated": ["plants", "Clinical studies", "Hypericum perforatum", "Ginkgo biloba", "Panax ginseng", "Allium sativum"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["drug-induced liver injury", "liver toxicity", "hepatotoxicity"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "worse than the disease", "Disease"], "gold": ["the Disease"]}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["rashes caused by Lomatium"], "gold": ["rashes", "the rash"]}, {"generated": ["rash", "pruritis"], "gold": ["the rash", "pruritis"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Day 5"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["OSA (Obesity Sleep Apnea)"], "gold": []}, {"generated": ["RLM", "hCE1"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["OSA", "OS"], "gold": []}, {"generated": ["OSA (Obstructive Sleep Apnoea)"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["herb/herbal component effect on OS"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Root of Isatis indigotica Fort., Banlangen"], "gold": []}, {"generated": ["Niubangzi"], "gold": []}, {"generated": ["clinical breast cancer"], "gold": ["breast cancer"]}, {"generated": [], "gold": []}, {"generated": ["breast cancer"], "gold": ["cancer", "breast cancer"]}, {"generated": [], "gold": []}, {"generated": ["Licorice (Glycyrrhiza glabra L.) - may cause hypokalemia, congestive heart failure, and edema", "Ginger (Zingiber officinale Roscoe) - may cause heartburn, diarrhea, and bleeding", "Lilyturf (Ophiopogon japonicus (Thunb.)) - may cause liver toxicity"], "gold": []}, {"generated": ["autophagy", "apoptosis", "cell cycle arrest"], "gold": ["anti-cancer", "apoptosis, autophagy, and cell cycle arrest"]}, {"generated": [], "gold": ["anti-proliferative effect", "apoptosis"]}, {"generated": ["T-47D", "MCF-7"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["TAM-resistant MCF-7/TAM-R cells"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": ["protective effect"]}, {"generated": ["TAM-intoxicated liver injury"], "gold": ["the oxidative stress", "liver injury"]}, {"generated": [], "gold": []}, {"generated": ["MDR1", "BCRP", "OAT1/3"], "gold": []}, {"generated": ["communicable diseases"], "gold": ["Communicable diseases"]}, {"generated": ["prostatitis", "urinary tract infections", "pyelonephritis"], "gold": ["urinary tract infections", "pyelonephritis", "prostatitis"]}, {"generated": [], "gold": []}, {"generated": ["CIP"], "gold": []}, {"generated": ["intestinal secretion", "secretion into breast milk", "biliary excretion"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["24% increase", "low to moderate exercise intensities"], "gold": []}, {"generated": [], "gold": ["healthy"]}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["concomitant herbal use"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["terminalia/commiphora ayurvedic mixture", "kratom", "ginseng", "rhodiola", "moringa", "valerian", "hydroxycut", "St. John\u2019s wort", "echinacea", "gingko", "piperine", "kava", "celery"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["consequences", "anecdotal evidence", "severity"], "gold": []}, {"generated": [], "gold": ["cognition decline", "memory loss", "anxiety", "mood disorders", "fatigue", "cardiovascular disorders"]}, {"generated": ["seizure"], "gold": ["seizure"]}, {"generated": [], "gold": []}, {"generated": ["manic psychosis"], "gold": ["manic psychosis"]}, {"generated": [""], "gold": []}, {"generated": ["general concern about its safety"], "gold": []}, {"generated": ["clinically relevant interaction"], "gold": []}, {"generated": [], "gold": ["diabetes", "diarrhea"]}, {"generated": ["interactions", "serotonergic effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["side effects", "herbal products"], "gold": []}, {"generated": ["marketed herbal products", "mixtures of different herbal species", "dietary supplements"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["interactions with specific neuropsychiatric drugs"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["immunosuppressive agents"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["tacrolimus-based immunosuppression", "tremors"], "gold": ["tremors"]}, {"generated": ["serum creatinine level"], "gold": []}, {"generated": ["adverse effects"], "gold": ["adverse effects"]}, {"generated": ["pharmacology"], "gold": []}, {"generated": ["immunosuppressive drug", "graft rejection"], "gold": ["graft rejection"]}, {"generated": ["immunosuppressive drugs"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["serum creatinine level"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacology"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["QT interval prolongation", "Zuccor phenomenon", "cardiac arrhythmias"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["combined extraction solution"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["Europe", "regulatory environment", "Bilia and C\u00e9u Costas review"], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["analgetic drugs", "non-pharmacological treatments"], "gold": []}, {"generated": ["frequently occurring species", "combined literature", "list of pathologies"], "gold": []}, {"generated": ["prevalence"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["Aloe vera"], "gold": []}, {"generated": ["hepatotoxic"], "gold": ["hepatotoxic"]}, {"generated": ["short-term use of opioids"], "gold": ["pain"]}, {"generated": ["liver injury"], "gold": ["liver injury"]}, {"generated": ["insufficiently defined product quality"], "gold": []}, {"generated": ["inflammatory diseases"], "gold": ["inflammatory diseases"]}, {"generated": ["possible beneficial effects"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["dry extract", "ginkgolic acid content"], "gold": []}, {"generated": ["severe bleeding events"], "gold": ["severe bleeding events", "bleeding risk"]}, {"generated": ["thrombin inhibition"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pathologies or side effects found in text"], "gold": []}, {"generated": ["HILI"], "gold": ["HILI"]}, {"generated": ["HILI"], "gold": ["HILI"]}, {"generated": ["no specific pathologies or side effects mentioned in the provided text"], "gold": []}, {"generated": ["individual genotype", "unusually susceptible"], "gold": []}, {"generated": ["CYP2D9", "CYP3A4"], "gold": []}, {"generated": ["platelet aggregation"], "gold": []}, {"generated": ["MTX doses", "ASA"], "gold": []}, {"generated": ["individual susceptibility"], "gold": []}, {"generated": ["side effects", "adverse effects"], "gold": ["adverse effects"]}, {"generated": [], "gold": []}, {"generated": ["side effects", "pharmacology", "pathologies"], "gold": []}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": ["Diabetes"], "gold": ["Diabetes"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["diabetic treatment"], "gold": ["diabetic"]}, {"generated": ["diabetes"], "gold": ["diabetes"]}, {"generated": [], "gold": []}, {"generated": ["conventional antidiabetics"], "gold": []}, {"generated": ["98"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": ["adverse reactions"]}, {"generated": ["pathologies or side effects"], "gold": []}, {"generated": ["bronchitis", "flatulence", "cough", "convulsions", "hysteria", "asthma"], "gold": ["flatulence", "cough", "asthma", "bronchitis", "hysteria", "convulsions"]}, {"generated": [], "gold": []}, {"generated": ["CYP2D6", "CYP3A"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["DOR (dihydrotestosterone)"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": ["healthy"]}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["abemaciclib-related diarrhea"], "gold": ["diarrhea"]}, {"generated": ["fatigue", "loose stools"], "gold": ["fatigue", "loose stools"]}]}